Evaluation of Antiemetic Therapy for Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin

por Zhao, Yang, He, MinKe, Liang, RunBin, Li, QiJiong, Shi, Ming
Publicado 2021

Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma

por Zhao, Yang, Lai, JiaYing, Liang, RunBin, He, MinKe, Shi, Ming
Publicado 2019

NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma

por Le, Yong, Kan, Anna, Li, Qi-Jiong, He, Min-Ke, Chen, Hai-Long, Shi, Ming
Publicado 2019

Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro

por Xu, Yu-Jie, He, Min-Ke, Liu, Shuang, Huang, Li-Chang, Bu, Xiao-Yun, Kan, Anna, Shi, Ming
Publicado 2021

Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study

por He, Min-Ke, Le, Yong, Li, Qi-Jiong, Yu, Zi-Shan, Li, Shao-Hua, Wei, Wei, Guo, Rong-Ping, Shi, Ming
Publicado 2017

Prognostic significance of sodium-potassium ATPase regulator, FXYD3, in human hepatocellular carcinoma

por Wang, Li-Juan, Li, Qi-Jiong, Le, Yong, Ouyang, Han-Yue, He, Min-Ke, Yu, Zi-Shan, Zhang, Yong-Fa, Shi, Ming
Publicado 2018

Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy

por Chen, Hai‐Long, OuYang, Han‐Yue, Le, Yong, Jiang, Peng, Tang, Hui, Yu, Zi‐Shan, He, Min‐Ke, Tang, Yun‐Qiang, Shi, Ming
Publicado 2018

Transarterial Chemoembolization related to Good Survival for Selected Patients with advanced Hepatocellular Carcinoma

por Le, Yong, Shen, Jing-Xian, Zhang, Yong-Fa, He, Min-Ke, Kan, Anna, Chen, Hai-Long, Yu, Zi-Shan, Li, Qi-Jiong, Shi, Ming
Publicado 2019

DNA methylation-activated full-length EMX1 facilitates metastasis through EMX1-EGFR-ERK axis in hepatocellular carcinoma

por Wen, Dong-sheng, Huang, Li-chang, Bu, Xiao-yun, He, Min-ke, Lai, Zhi-cheng, Du, Ze-feng, Huang, Ye-xing, Kan, Anna, Shi, Ming
Publicado 2023

Predictive factors for the benefit of triple‐drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma

por He, MinKe, Li, Qing, Shen, JingXian, Tan, GuoSheng, Li, QiJiong, Lai, JiaYing, Wei, Wei, Zhang, YaoJun, Zou, RuHai, Chen, MinShan, Guo, RongPing, Shi, Ming
Publicado 2019

Toripalimab Combined With Hepatic Arterial Infusion Chemotherapy Versus Lenvatinib for Advanced Hepatocellular Carcinoma

por Xu, Yu-Jie, Lai, Zhi-Cheng, He, Min-Ke, Bu, Xiao-Yun, Chen, Huan-Wei, Zhou, Yuan-Min, Xu, Li, Wei, Wei, Zhang, Yao-Jun, Chen, Min-Shan, Guo, Rong-Ping, Shi, Ming, Li, Qi-Jiong
Publicado 2021

Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy versus lenvatinib alone for advanced hepatocellular carcinoma

por He, Min-Ke, Liang, Run-Bin, Zhao, Yang, Xu, Yu-Jie, Chen, Huan-Wei, Zhou, Yuan-Min, Lai, Zhi-Cheng, Xu, Li, Wei, Wei, Zhang, Yao-Jun, Chen, Min-Shan, Guo, Rong-Ping, Li, Qi-Jiong, Shi, Ming
Publicado 2021

Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular Carcinoma

por Liang, Run-Bin, Zhao, Yang, He, Min-Ke, Wen, Dong-Sheng, Bu, Xiao-Yun, Huang, Ye-Xing, Lai, Zhi-Cheng, Xu, Yu-Jie, Kan, Anna, Wei, Wei, Zhang, Yao-Jun, Chen, Min-Shan, Guo, Rong-Ping, Li, Qi-Jiong, Shi, Ming
Publicado 2021

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Su...

por Huang, YeXing, Zhang, LiHong, He, MinKe, Lai, ZhiCheng, Bu, XiaoYun, Wen, DongSheng, Li, QiJiong, Xu, Li, Wei, Wei, Zhang, YaoJun, Zhou, ZhongGuo, Chen, MinShan, Guo, RongPing, Shi, Ming, Kan, Anna
Publicado 2022